Struvite (infection) stones and staghorn calculi
struvite · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Magnesium-ammonium-phosphate stones formed in persistently alkaline urine from urease-producing organisms (Proteus, Klebsiella). They grow rapidly into staghorn calculi, harbour chronic infection and require complete surgical clearance plus infection control.
Red flags
- Fever/sepsis with obstruction (pyonephrosis) — emergency decompression
- Rapidly enlarging staghorn calculus
- Deteriorating renal function or bilateral disease
- Recurrent urosepsis despite therapy
- Non-functioning infected kidney
Assessment
Differential diagnosis
- Staghorn struvite calculus
- Cystine staghorn stone
- Uric acid stone
- Calcium phosphate stone
- Matrix stone
- Infected non-struvite stone
Investigations
- Non-contrast CT KUB (stone burden/branching)
- Urinalysis (alkaline pH, pyuria) and urine culture
- Stone analysis
- U&E and split renal function (DMSA/MAG3) if nephrectomy considered
- FBC/CRP for infection severity
- Serum calcium/urate to exclude metabolic contributors
Management
- Confirm struvite/infected staghorn stone on imaging and culture urease-producing organisms
- Assess for sepsis and obstruction — treat infected obstruction as an emergency with decompression (stent/nephrostomy) and antibiotics
- Plan definitive complete stone removal — residual fragments perpetuate infection and recurrence
- Percutaneous nephrolithotomy (PCNL) is first-line for staghorn calculi, with adjunctive flexible ureteroscopy/ESWL as needed
- Culture-directed perioperative antibiotics to minimise urosepsis risk
- Aim for a stone-free kidney; re-image to confirm clearance
- Treat underlying contributors (obstruction, foreign body/catheter, neurogenic bladder)
- Consider urease inhibitor (acetohydroxamic acid) only if surgery impossible and infection persists
- Provide long-term antibiotic suppression where recurrent infection persists and surveillance imaging
- Assess and preserve renal function; consider nephrectomy for a non-functioning infected kidney
- Give general stone prevention advice and metabolic screen for coexisting stones
- Arrange regular urological follow-up with imaging and cultures
Drugs & doses
Culture-directed IV antibiotics for urosepsis (e.g. gentamicin 5-7 mg/kg IV daily + amoxicillin, per local policy)
Co-amoxiclav 625 mg PO three times daily (culture-directed oral option)
Acetohydroxamic acid 250 mg PO three times daily (urease inhibitor; only if surgery not feasible, monitor for toxicity)
Low-dose suppressive antibiotic (e.g. trimethoprim 100 mg PO nightly) per sensitivities
Disposition
Urology admission for definitive stone clearance; emergency decompression for pyonephrosis. Infectious/nephrology input for complex cases and long-term surveillance.
Complications & pitfalls
- Pyonephrosis and urosepsis
- Progressive CKD and loss of the kidney
- Xanthogranulomatous pyelonephritis
- Recurrence from residual fragments
- Rarely, squamous cell carcinoma in chronically infected stones
Exam pearls
- Struvite stones require complete removal — leaving fragments guarantees recurrence
- Think urease-producers (Proteus) with persistently alkaline urine
- Infected obstruction is a surgical emergency, not a prescription for antibiotics alone
- PCNL is the definitive treatment for staghorn calculi
- Acetohydroxamic acid is toxic and reserved for inoperable cases
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.